Patent · US Active

Modified growth hormones

US7998930B2 · kind B2 · utility

12Cited by

102References

12Claims

0Family size

Assignee

HANALL BIOPHARMA CO., LTD. · KR

Inventors

Thierry Guyon · Palaiseau, FR
Gilles Borrelly · Épinay-sous-Sénart, FR
Lila Drittanti · Vigneux-sur-Seine, FR
Manuel Vega · Vigneux-sur-Seine, FR

Key dates

Filing date	Nov 3, 2005
Grant date	Aug 16, 2011
Priority date	—
Expiry date	Oct 4, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are modified growth hormone polypeptides, nucleic acid molecules encoding modified growth hormone polypeptides and methods of generating modified growth hormone polypeptides. Also provided are methods of treatment using modified growth hormone polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.